Avoro Capital Advisors LLC - 31 Dec 2025 SCHEDULE 13G Report for SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share (SLNO)

Filing Manager
Avoro Capital Advisors LLC
Reporting Manager
Avoro Capital Advisors LLC
Security
SOLENO THERAPEUTICS INC Common Stock, par value $0.001 per share
Symbol
SLNO
Shares outstanding
53,703,704 shares
Disclosed Ownership
2,900,000 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
17 Feb 2026, 09:01:41 UTC
Date of event
31 Dec 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Avoro Capital Advisors LLC 5.4% 2,900,000 2,900,000 0 /s/ Scott Epstein Scott Epstein, Chief Operating Officer and Chief Compliance Officer
Behzad Aghazadeh 5.4% 2,900,000 2,900,000 0 /s/ Behzad Aghazadeh Behzad Aghazadeh, Individually